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Background
It is estimated that around 15% of HIV infected patients
are being followed in HIV units for disease evolution
and need of treatment. Data on the demographics and
HIV disease status of these patients are scarce.
Methods
Cross sectional analysis within 12 HIV units in Spain
with the aim of describing the characteristics of patients
in care but not on treatment. We collected data on
demographics, HIV disease status as well as the preva-
lence of non-HIV co-morbidities that could qualify for
antiretroviral treatment initiation regardless immunolo-
gical status according to current Spanish treatment
guidelines.
Results
Data from 865 patients naïve to ARV treatment were
collected. Mean age 37 y, most of them were male
(83%) and Caucasian (85%). Predominant HIV risk fac-
tor was MSM (56%). Median time from HIV diagnosis
2.3 y (IQR 1.0 to 5.1). Current median CD4 cell count
was 602 /mm
3 (IQR 422 to 729) and mean HIV-1 RNA
levels were 4.6 log.
The prevalence of key HIV and non-HIV features
according to different CD4 strata can be seen in Table 1
Conclusions
In our cohort of patients who are under care but not on
treatment, a considerable amount of them could benefit
from treatment initiation according to current guide-
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Table 1
CD4<350 (n=112) CD4 350 - 500 (n=261) CD4>500 (n=492)
>55 years of age 1.8% 3.1% 2.6%
HIV RNA >100,000 cop/mL 20.5% 13.4% 8.1%
CD4 percentage < 14% 19.6% 3.1% 1.2%
HCV coinfection 25.0% 14.2% 14.0%
HBV coinfection requiring treatment† 0% 0.4% 0%
Liver cirrhosis 4.5% 1.1% 1.6%
HIV associated nephropaty 0% 0.8% 0%
10 y CHD>20% (Framinghan score)‡ Not available Not available 0.8%
†: According to Spanish guidelines ‡: Data not available for 30% of the subjects
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lines are being followed, non HIV comorbidities should
also be taken into account. Among these patients, HCV
coinfection is the most prevalent comorbidity. Some of
these patients could also benef i tf r o mg e n e r a l i s a t i o no f
cardiovascular risk evaluation in HIV units.
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